PTC Therapeutics PTCT Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by PTC Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent.
The official record: PTC Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about PTC Therapeutics's accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is PTC Therapeutics's accounts payable?
- PTC Therapeutics (PTCT) reported accounts payable of $313.05M in Q1 2026.
- How has PTC Therapeutics's accounts payable changed year-over-year?
- PTC Therapeutics's accounts payable decreased by 1.5% year-over-year, from $317.81M to $313.05M.
- What is the long-term trend for PTC Therapeutics's accounts payable?
- Over 5 years (2020 to 2025), PTC Therapeutics's accounts payable has grown at a 9.5% compound annual growth rate (CAGR), from $242.17M to $381.27M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.